NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

奈米孔洞定序的全球市場 - 各產品,各核苷酸序列,各類型,奈米孔洞的各類型,各用途,各終端用戶,各地區,競爭預測,機會:2026年

Global Nanopore Sequencing Market, By Product, By Nucleotide Sequenced, By Type, By Type of Nanopore, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026

出版商 TechSci Research 商品編碼 1021846
出版日期 內容資訊 英文 117 Pages
商品交期: 2-3個工作天內
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

奈米孔洞定序的全球市場 - 各產品,各核苷酸序列,各類型,奈米孔洞的各類型,各用途,各終端用戶,各地區,競爭預測,機會:2026年 Global Nanopore Sequencing Market, By Product, By Nucleotide Sequenced, By Type, By Type of Nanopore, By Application, By End User, By Region, Competition Forecast & Opportunities, 2026
出版日期: 2021年08月01日內容資訊: 英文 117 Pages
簡介

全球奈米孔洞定序市場,2020年達到2億3,691萬美元,在預測期間內預計強力成長15.29%。

這個成長,起因於對DNA定序、RNA定序的長先導定序技術的全球需求高漲。

本報告提供全球奈米孔洞定序市場相關調查分析,市場規模、佔有率、預測,各市場區隔分析,競爭分析,市場趨勢的變化,新興機會相關的系統性資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 COVID-19對全球奈米孔洞定序市場的影響

第4章 摘要整理

第5章 客戶的迴響 (VOC)

第6章 全球奈米孔洞定序市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品 (消耗品 vs. 設備)
    • 各核苷酸序列 (DNA vs. RNA)
    • 各類型 (Direct Current Sequencing,Synthetic DNA and Horizontal Tunnelling Current Sequencing,Optical Reading Techniques Sequencing,Exonuclease Sequencing)
    • 奈米孔洞的各類型 (固體,生物學的,混合)
    • 各用途 (人類遺傳學,臨床研究,植物研究,微生物學,動物研究)
    • 各終端用戶 (生物科技企業,臨床檢驗室,學術、研究機關)
    • 各地區
    • 各企業
  • 產品市場地圖

第7章 北美的奈米孔洞定序市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品
    • 各核苷酸序列
    • 各類型
    • 奈米孔洞的各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 北美:各國分析
    • 美國的奈米孔洞定序市場預測
    • 加拿大的奈米孔洞定序市場預測
    • 墨西哥的奈米孔洞定序市場預測

第8章 歐洲的奈米孔洞定序市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品
    • 各核苷酸序列
    • 各類型
    • 奈米孔洞的各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 歐洲:各國分析
    • 英國的奈米孔洞定序市場預測
    • 德國的奈米孔洞定序市場預測
    • 法國的奈米孔洞定序市場預測
    • 俄羅斯的奈米孔洞定序市場預測
    • 土耳其的奈米孔洞定序市場預測
    • 西班牙的奈米孔洞定序市場預測

第9章 亞太地區的奈米孔洞定序市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品
    • 各核苷酸序列
    • 各類型
    • 奈米孔洞的各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 亞太地區:各國分析
    • 中國的奈米孔洞定序市場預測
    • 日本的奈米孔洞定序市場預測
    • 印度的奈米孔洞定序市場預測
    • 新加坡的奈米孔洞定序市場預測
    • 台灣的奈米孔洞定序市場預測
    • 澳洲的奈米孔洞定序市場預測
    • 韓國的奈米孔洞定序市場預測

第10章 南美的奈米孔洞定序市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品
    • 各核苷酸序列
    • 各類型
    • 奈米孔洞的各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 南美:各國分析
    • 巴西的奈米孔洞定序市場預測
    • 阿根廷的奈米孔洞定序市場預測
    • 哥倫比亞的奈米孔洞定序市場預測

第11章 中東、非洲的奈米孔洞定序市場預測

  • 市場規模與預測
    • 各金額
  • 市場佔有率與預測
    • 各產品
    • 各核苷酸序列
    • 各類型
    • 奈米孔洞的各類型
    • 各用途
    • 各終端用戶
    • 各國
  • 中東、非洲:各國分析
    • 阿拉伯聯合大公國的奈米孔洞定序市場預測
    • 沙烏地阿拉伯的奈米孔洞定序市場預測
    • 以色列的奈米孔洞定序市場預測
    • 南非的奈米孔洞定序市場預測

第12章 市場動態

  • 促進因素
  • 課題

第13章 市場趨勢與發展

第14章 競爭情形

  • 競爭預測
  • 企業簡介
    • Oxford Nanopore Technologies Ltd
    • Illumnia,Inc.
    • F Hoffmann-La Roche AG
    • 10X Genomics,Inc.
    • Agilent Technologies Inc.
    • NabSys,Inc.
    • Sequenom,Inc.
    • Quantapore,Inc
    • INanoBio Inc
    • Thermo Fischer Scientific,Inc.
    • Cyclomics BV
    • CD Genomics
    • Electronic Biosciences,Inc.
    • Easi-Genomics

第15章 策略性建議

第16章 出版社、免責聲明

目錄
Product Code: 7677

Global nanopore sequencing market stood at USD236.91 million in 2020 and is expected to grow at a robust rate of 15.29% during the forecast period. This growth can be attributed to the growing demand for long read sequencing technologies for DNA and RNA sequencing worldwide. Additionally, benefits such as affordability, high accuracy, simultaneous detection of sequences and base modifications, among others associated with nanopore sequencing technology are further expected to fuel the market growth through 2026. Nanopore sequencing provides targeted sequencing with focus on specific genes thereby providing relevant data, optimizing costs and providing path for simplified data analysis. This in turn is expected to support the market growth over the next few years. Besides, the biggest advantage of directly sequencing RNA molecules using the nanopore sequencing is expected to foster the market growth. In traditional RNA sequencing technologies RNA is first converted to cDNA using amplification or reverse transcription which at time introduces bias in the sequencing. However, with nanopore sequencing direct RNA sequencing can be done and it delivers unbiased, full length and highly specific RNA sequences. All these factors are expected to contribute to the market growth in the next five years.

The global nanopore sequencing market is segmented by product, nucleotide sequenced, type, type of nanopore, application, end user, competitional landscape, and regional distribution. Based on product, the market can be split into consumables and instruments. The consumables segment dominated the market in 2020 with a share of around 53.86%. This can be attributed to surge in use of consumables in wide array of procedures such as DNA sequencing and RNA sequencing. In addition, increase in usage of consumables in formerly unmapped applications such as sequencing of novel viruses is expected to help the segment gain significant share during the forecast period.

Major players operating in the global nanopore sequencing market include Oxford Nanopore Technologies Ltd, Illumnia, Inc., F Hoffmann-La Roche AG, 10X Genomics, Inc., Agilent Technologies Inc., NabSys, Inc., Sequenom, Inc., Quantapore, Inc, INanoBio Inc, Thermo Fischer Scientific, Inc., Cyclomics BV, CD Genomics, Electronic Biosciences, Inc., Easi-Genomics, among others. The players operating in the market are following strategies such as mergers & acquisitions, new product/technology development and launches in order to stay competitive in the market and having an edge over the competitors. For instance, in the nanopore sequencing market its Oxford Nanopore Technologies Ltd. which is the pioneer of the technology and dominates the overall nanopore sequencing market. The company is expanding worldwide, opening subsidiaries, launching new products & instruments and investing in development of nanopore sequencing. For instance, in July 2019, Oxford Nanopore Technologies introduced GridION Mk1, a device which can be used to perform PCR-free analysis of cancer-related genes. Additionally, researchers at Fuyang City (China) were the first to sequence COVID-19 samples using Oxford Nanopore Technologies (UK) MinION Mk1C. The team is part of a growing network of public health and CDC labs in China that are deploying Nanopore products for rapid epidemiological surveillance. In February 2019, Nanopore deployed 200 MinIONs to China, and many of these are now in use for viral and bacterial sequencing surveillance programs.

Years considered for this report:

Historical Years: 2016 - 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 - 2026

Objective of the Study:

  • To analyze the historical growth in the market size of global nanopore sequencing market from 2016 to 2020.
  • To estimate and forecast the market size of global nanopore sequencing market from 2021 to 2026 and growth rate until 2026.
  • To classify and forecast global nanopore sequencing market based on product, nucleotide sequenced, type, type of nanopore, application, end user, region and company.
  • To identify dominant region or segment in the global nanopore sequencing market.
  • To identify drivers and challenges for global nanopore sequencing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global nanopore sequencing market.
  • To identify and analyze the profile of leading players operating in global nanopore sequencing market.
  • To identify key sustainable strategies adopted by market players in global nanopore sequencing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of service providers, instrument & consumables manufacturers and distributors across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the service providers, instrument & consumables manufacturers and distributors and presence of all major players across the globe.

TechSci Research calculated the market size of global nanopore sequencing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Sequencing Service Providers
  • Academic & Research Institutes, Biotechnology Companies and other stakeholders
  • Manufacturers, distributors and suppliers of instruments, consumables and other stakeholders
  • Organizations, forums, and alliances related to nanopore sequencing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as instrument & consumables manufacturers, suppliers, sequencing service providers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global nanopore sequencing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Nanopore Sequencing Market, By Product:

Consumables

Instruments

  • Global Nanopore Sequencing Market, By Nucleotide Sequenced:

DNA

RNA

  • Global Nanopore Sequencing Market, By Type:

Direct Current Sequencing

Synthetic DNA and Horizontal Tunnelling Current Sequencing

Optical Reading Techniques Sequencing

Exonuclease Sequencing

  • Global Nanopore Sequencing Market, By Type of Nanopore:

Solid State

Biological

Hybrid

  • Global Nanopore Sequencing Market, By Application:

Human Genomics

Clinical Research

Plant Research

Microbiology

Animal Research

  • Global Nanopore Sequencing Market, By End User:

Biotechnology Companies

Clinical Laboratories

Academic & Research Institutes

  • Global Nanopore Sequencing Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • United Kingdom
  • Germany
  • France
  • Russia
  • Turkey
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • Singapore
  • Taiwan
  • Australia
  • South Korea

South America

  • Brazil
  • Argentina
  • Colombia

Middle East & Africa

  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global nanopore sequencing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Nanopore Sequencing Market

4. Executive Summary

5. Voice of Customer

  • 5.1. Product/Service Awareness
  • 5.2. Brand Awareness
  • 5.3. Factors affecting the choice of Nanopore
  • 5.4. Commonly Used Nanopore Sequencing Methods
  • 5.5. Factors Leading to adoption of Nanopore Sequencing

6. Global Nanopore Sequencing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Consumables v/s Instruments)
    • 6.2.2. By Nucleotide Sequenced (DNA v/s RNA)
    • 6.2.3. By Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing)
    • 6.2.4. By Type of Nanopore (Solid State, Biological, Hybrid)
    • 6.2.5. By Application (Human Genetics, Clinical Research, Plant Research, Microbiology, Animal Research)
    • 6.2.6. By End User (Biotechnology Companies, Clinical Laboratories, Academic & Research Institutes)
    • 6.2.7. By Region
    • 6.2.8. By Company (2020)
  • 6.3. Product Market Map

7. North America Nanopore Sequencing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Nucleotide Sequenced
    • 7.2.3. By Type
    • 7.2.4. By Type of Nanopore
    • 7.2.5. By Application
    • 7.2.6. By End User
    • 7.2.7. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Nanopore Sequencing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Nucleotide Sequenced
        • 7.3.1.2.3. By Type
        • 7.3.1.2.4. By Type of Nanopore
        • 7.3.1.2.5. By Application
        • 7.3.1.2.6. By End User
    • 7.3.2. Canada Nanopore Sequencing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Nucleotide Sequenced
        • 7.3.2.2.3. By Type
        • 7.3.2.2.4. By Type of Nanopore
        • 7.3.2.2.5. By Application
        • 7.3.2.2.6. By End User
    • 7.3.3. Mexico Nanopore Sequencing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Nucleotide Sequenced
        • 7.3.3.2.3. By Type
        • 7.3.3.2.4. By Type of Nanopore
        • 7.3.3.2.5. By Application
        • 7.3.3.2.6. By End User

8. Europe Nanopore Sequencing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Nucleotide Sequenced
    • 8.2.3. By Type
    • 8.2.4. By Type of Nanopore
    • 8.2.5. By Application
    • 8.2.6. By End User
    • 8.2.7. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. United Kingdom Nanopore Sequencing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Nucleotide Sequenced
        • 8.3.1.2.3. By Type
        • 8.3.1.2.4. By Type of Nanopore
        • 8.3.1.2.5. By Application
        • 8.3.1.2.6. By End User
    • 8.3.2. Germany Nanopore Sequencing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Nucleotide Sequenced
        • 8.3.2.2.3. By Type
        • 8.3.2.2.4. By Type of Nanopore
        • 8.3.2.2.5. By Application
        • 8.3.2.2.6. By End User
    • 8.3.3. France Nanopore Sequencing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Nucleotide Sequenced
        • 8.3.3.2.3. By Type
        • 8.3.3.2.4. By Type of Nanopore
        • 8.3.3.2.5. By Application
        • 8.3.3.2.6. By End User
    • 8.3.4. Russia Nanopore Sequencing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Nucleotide Sequenced
        • 8.3.4.2.3. By Type
        • 8.3.4.2.4. By Type of Nanopore
        • 8.3.4.2.5. By Application
        • 8.3.4.2.6. By End User
    • 8.3.5. Turkey Nanopore Sequencing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Nucleotide Sequenced
        • 8.3.5.2.3. By Type
        • 8.3.5.2.4. By Type of Nanopore
        • 8.3.5.2.5. By Application
        • 8.3.5.2.6. By End User
    • 8.3.6. Spain Nanopore Sequencing Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Product
        • 8.3.6.2.2. By Nucleotide Sequenced
        • 8.3.6.2.3. By Type
        • 8.3.6.2.4. By Type of Nanopore
        • 8.3.6.2.5. By Application
        • 8.3.6.2.6. By End User

9. Asia-Pacific Nanopore Sequencing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Nucleotide Sequenced
    • 9.2.3. By Type
    • 9.2.4. By Type of Nanopore
    • 9.2.5. By Application
    • 9.2.6. By End User
    • 9.2.7. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Nanopore Sequencing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Nucleotide Sequenced
        • 9.3.1.2.3. By Type
        • 9.3.1.2.4. By Type of Nanopore
        • 9.3.1.2.5. By Application
        • 9.3.1.2.6. By End User
    • 9.3.2. Japan Nanopore Sequencing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Nucleotide Sequenced
        • 9.3.2.2.3. By Type
        • 9.3.2.2.4. By Type of Nanopore
        • 9.3.2.2.5. By Application
        • 9.3.2.2.6. By End User
    • 9.3.3. India Nanopore Sequencing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Nucleotide Sequenced
        • 9.3.3.2.3. By Type
        • 9.3.3.2.4. By Type of Nanopore
        • 9.3.3.2.5. By Application
        • 9.3.3.2.6. By End User
    • 9.3.4. Singapore Nanopore Sequencing Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product
        • 9.3.4.2.2. By Nucleotide Sequenced
        • 9.3.4.2.3. By Type
        • 9.3.4.2.4. By Type of Nanopore
        • 9.3.4.2.5. By Application
        • 9.3.4.2.6. By End User
    • 9.3.5. Taiwan Nanopore Sequencing Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product
        • 9.3.5.2.2. By Nucleotide Sequenced
        • 9.3.5.2.3. By Type
        • 9.3.5.2.4. By Type of Nanopore
        • 9.3.5.2.5. By Application
        • 9.3.5.2.6. By End User
    • 9.3.6. Australia Nanopore Sequencing Market Outlook
      • 9.3.6.1. Market Size & Forecast
        • 9.3.6.1.1. By Value
      • 9.3.6.2. Market Share & Forecast
        • 9.3.6.2.1. By Product
        • 9.3.6.2.2. By Nucleotide Sequenced
        • 9.3.6.2.3. By Type
        • 9.3.6.2.4. By Type of Nanopore
        • 9.3.6.2.5. By Application
        • 9.3.6.2.6. By End User
    • 9.3.7. South Korea Nanopore Sequencing Market Outlook
      • 9.3.7.1. Market Size & Forecast
        • 9.3.7.1.1. By Value
      • 9.3.7.2. Market Share & Forecast
        • 9.3.7.2.1. By Product
        • 9.3.7.2.2. By Nucleotide Sequenced
        • 9.3.7.2.3. By Type
        • 9.3.7.2.4. By Type of Nanopore
        • 9.3.7.2.5. By Application
        • 9.3.7.2.6. By End User

10. South America Nanopore Sequencing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Nucleotide Sequenced
    • 10.2.3. By Type
    • 10.2.4. By Type of Nanopore
    • 10.2.5. By Application
    • 10.2.6. By End User
    • 10.2.7. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Nanopore Sequencing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Nucleotide Sequenced
        • 10.3.1.2.3. By Type
        • 10.3.1.2.4. By Type of Nanopore
        • 10.3.1.2.5. By Application
        • 10.3.1.2.6. By End User
    • 10.3.2. Argentina Nanopore Sequencing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Nucleotide Sequenced
        • 10.3.2.2.3. By Type
        • 10.3.2.2.4. By Type of Nanopore
        • 10.3.2.2.5. By Application
        • 10.3.2.2.6. By End User
    • 10.3.3. Colombia Nanopore Sequencing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Nucleotide Sequenced
        • 10.3.3.2.3. By Type
        • 10.3.3.2.4. By Type of Nanopore
        • 10.3.3.2.5. By Application
        • 10.3.3.2.6. By End User

11. Middle East and Africa Nanopore Sequencing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Nucleotide Sequenced
    • 11.2.3. By Type
    • 11.2.4. By Type of Nanopore
    • 11.2.5. By Application
    • 11.2.6. By End User
    • 11.2.7. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. UAE Nanopore Sequencing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Nucleotide Sequenced
        • 11.3.1.2.3. By Type
        • 11.3.1.2.4. By Type of Nanopore
        • 11.3.1.2.5. By Application
        • 11.3.1.2.6. By End User
    • 11.3.2. Saudi Arabia Nanopore Sequencing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Nucleotide Sequenced
        • 11.3.2.2.3. By Type
        • 11.3.2.2.4. By Type of Nanopore
        • 11.3.2.2.5. By Application
        • 11.3.2.2.6. By End User
    • 11.3.3. Israel Nanopore Sequencing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Nucleotide Sequenced
        • 11.3.3.2.3. By Type
        • 11.3.3.2.4. By Type of Nanopore
        • 11.3.3.2.5. By Application
        • 11.3.3.2.6. By End User
    • 11.3.4. South Africa Nanopore Sequencing Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product
        • 11.3.4.2.2. By Nucleotide Sequenced
        • 11.3.4.2.3. By Type
        • 11.3.4.2.4. By Type of Nanopore
        • 11.3.4.2.5. By Application
        • 11.3.4.2.6. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles (SWOT Analysis of Top 5 Players Profiled)
    • 14.2.1. Oxford Nanopore Technologies Ltd
    • 14.2.2. Illumnia, Inc.
    • 14.2.3. F Hoffmann-La Roche AG
    • 14.2.4. 10X Genomics, Inc.
    • 14.2.5. Agilent Technologies Inc.
    • 14.2.6. NabSys, Inc.
    • 14.2.7. Sequenom, Inc.
    • 14.2.8. Quantapore, Inc
    • 14.2.9. INanoBio Inc
    • 14.2.10. Thermo Fischer Scientific, Inc.
    • 14.2.11. Cyclomics BV
    • 14.2.12. CD Genomics
    • 14.2.13. Electronic Biosciences, Inc.
    • 14.2.14. Easi-Genomics

15. Strategic Recommendations

16. About Us & Disclaimer

List of Figures

  • Figure 1: Global Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 2: Global Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 3: Global Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 4: Global Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 5: Global Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 6: Global Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 7: Global Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 8: Global Nanopore Sequencing Market Share, By Region, By Value, 2016-2026F
  • Figure 9: Global Nanopore Sequencing Market Share, By Company, By Value, 2020
  • Figure 10: North America Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 11: North America Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 12: North America Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 13: North America Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 14: North America Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 15: North America Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 16: North America Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 17: North America Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
  • Figure 18: United States Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 19: United States Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 20: United States Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 21: United States Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 22: United States Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 23: United States Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 24: United States Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 25: Canada Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 26: Canada Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 27: Canada Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 28: Canada Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 29: Canada Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 30: Canada Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 31: Canada Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 32: Mexico Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 33: Mexico Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 34: Mexico Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 35: Mexico Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 36: Mexico Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 37: Mexico Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 38: Mexico Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 39: Europe Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 40: Europe Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 41: Europe Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 42: Europe Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 43: Europe Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 44: Europe Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 45: Europe Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 46: Europe Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
  • Figure 47: United Kingdom Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 48: United Kingdom Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 49: United Kingdom Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 50: United Kingdom Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 51: United Kingdom Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 52: United Kingdom Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 53: United Kingdom Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 54: Germany Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 55: Germany Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 56: Germany Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 57: Germany Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 58: Germany Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 59: Germany Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 60: Germany Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 61: France Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 62: France Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 63: France Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 64: France Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 65: France Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 66: France Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 67: France Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 68: Russia Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 69: Russia Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 70: Russia Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 71: Russia Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 72: Russia Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 73: Russia Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 74: Russia Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 75: Turkey Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 76: Turkey Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 77: Turkey Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 78: Turkey Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 79: Turkey Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 80: Turkey Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 81: Turkey Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 82: Spain Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 83: Spain Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 84: Spain Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 85: Spain Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 86: Spain Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 87: Spain Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 88: Spain Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 89: Asia Pacific Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 90: Asia Pacific Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 91: Asia Pacific Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 92: Asia Pacific Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 93: Asia Pacific Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 94: Asia Pacific Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 95: Asia Pacific Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 96: Asia Pacific Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
  • Figure 97: China Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 98: China Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 99: China Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 100: China Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 101: China Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 102: China Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 103: China Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 104: Japan Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 105: Japan Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 106: Japan Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 107: Japan Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 108: Japan Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 109: Japan Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 110: Japan Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 111: India Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 112: India Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 113: India Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 114: India Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 115: India Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 116: India Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 117: India Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 118: Singapore Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 119: Singapore Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 120: Singapore Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 121: Singapore Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 122: Singapore Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 123: Singapore Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 124: Singapore Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 125: Taiwan Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 126: Taiwan Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 127: Taiwan Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 128: Taiwan Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 129: Taiwan Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 130: Taiwan Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 131: Taiwan Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 132: Australia Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 133: Australia Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 134: Australia Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 135: Australia Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 136: Australia Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 137: Australia Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 138: Australia Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 139: South Korea Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 140: South Korea Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 141: South Korea Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 142: South Korea Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 143: South Korea Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 144: South Korea Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 145: South Korea Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 146: South America Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 147: South America Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 148: South America Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 149: South America Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 150: South America Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 151: South America Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 152: South America Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 153: South America Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
  • Figure 154: Brazil Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 155: Brazil Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 156: Brazil Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 157: Brazil Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 158: Brazil Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 159: Brazil Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 160: Brazil Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 161: Argentina Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 162: Argentina Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 163: Argentina Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 164: Argentina Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 165: Argentina Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 166: Argentina Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 167: Argentina Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 168: Colombia Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 169: Colombia Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 170: Colombia Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 171: Colombia Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 172: Colombia Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 173: Colombia Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 174: Colombia Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 175: Middle East & Africa Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 176: Middle East & Africa Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 177: Middle East & Africa Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 178: Middle East & Africa Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 179: Middle East & Africa Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 180: Middle East & Africa Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 181: Middle East & Africa Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 182: Middle East & Africa Nanopore Sequencing Market Share, By Country, By Value, 2016-2026F
  • Figure 183: UAE Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 184: UAE Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 185: UAE Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 186: UAE Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 187: UAE Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 188: UAE Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 189: UAE Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 190: Saudi Arabia Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 191: Saudi Arabia Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 192: Saudi Arabia Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 193: Saudi Arabia Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 194: Saudi Arabia Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 195: Saudi Arabia Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 196: Saudi Arabia Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 197: Israel Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 198: Israel Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 199: Israel Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 200: Israel Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 201: Israel Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 202: Israel Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 203: Israel Nanopore Sequencing Market Share, By End User, By Value, 2016-2026
  • Figure 204: South Africa Nanopore Sequencing Market Size, By Value (USD Million), 2016-2026F
  • Figure 205: South Africa Nanopore Sequencing Market Share, By Product, By Value, 2016-2026F
  • Figure 206: South Africa Nanopore Sequencing Market Share, By Nucleotide Sequenced, By Value, 2016-2026F
  • Figure 207: South Africa Nanopore Sequencing Market Share, By Type, By Value, 2016-2026F
  • Figure 208: South Africa Nanopore Sequencing Market Share, By Type of Nanopore, By Value, 2016-2026F
  • Figure 209: South Africa Nanopore Sequencing Market Share, By Application, By Value, 2016-2026F
  • Figure 210: South Africa Nanopore Sequencing Market Share, By End User, By Value, 2016-2026